re: Ann: 2nd Quarter Dose Sales Growth 21.6 p... Not sure the result is all that good. Europe had a shocker. Question I have is why. No associated commentary. How long till other regions drop? Is Europe related to their economic issues?
- Forums
- ASX - By Stock
- SRX
- Ann: 2nd Quarter Dose Sales Growth 21.6 per cent
Ann: 2nd Quarter Dose Sales Growth 21.6 per cent , page-3
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online